Dr. Reddys Laboratories Ltd 2017 SR
The report highlights Dr. Reddy's sustainability performance for FY 2016-17, focusing on its 'Beyond compliance' approach. Key achievements include being the first Indian pharmaceutical company included in the Dow Jones Sustainability Index for Emerging Markets. The company achieved zero hazardous waste to landfill across all API manufacturing units in India and reduced specific energy consumption by 6.7%. It also began aligning its focus areas with the UN Sustainable Development Goals. The report details initiatives in affordable medicine and patient-centric care through the Purple Health platform.
Company: Dr. Reddys Laboratories Ltd
Sector: Health Care
Country: India
Year: 2017
Type: SR
Pages: 124
Dr. Reddys Laboratories Ltd
The report highlights Dr. Reddy's sustainability performance for FY 2016-17, focusing on its 'Beyond compliance' approach. Key achievements include being the first Indian pharmaceutical company included in the Dow Jones Sustainability Index for Emerging Markets. The company achieved zero hazardous waste to landfill across all API manufacturing units in India and reduced specific energy consumption by 6.7%. It also began aligning its focus areas with the UN Sustainable Development Goals. The report details initiatives in affordable medicine and patient-centric care through the Purple Health platform.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Apr 1, 2016 - Mar 31, 2017
Fiscal Year
2017
Published
Sep 20, 2017
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Workplace Fatalities
Employees